跳至主要内容
临床试验/ACTRN12614000320651
ACTRN12614000320651已完成4 期

The Effects of Allopurinol on Metabolic Acidosis and Endothelial Functions in Chronic Kidney Disease Patients

Dilara Bayram0 个研究点目标入组 60 人开始时间: 2014年3月26日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • The inclusion criteria were as follows; being a CKD patient at stage 2-4, age between 18 and 80 years old, having serum uric acid levels over 5.5 mg/dl and giving written informed consent to enter this study.

排除标准

  • The exclusion criteria were: being on renal replacement therapy, hyperuricemia due to malignancy, having peripheral arterial disease, gouty arthritis, a history of allopurinol intolerance, being already on allopurinol treatment, having active infections or inflammatory diseases.

研究者

发起方
Dilara Bayram

相似试验